![semaglutide 2.4 mg weekly PDF] 2·4 once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Semaglutide versus placebo in individuals](https://figures.semanticscholar.org/898978c1b0543b943d605e293f5296fb7568cee7/9-Table2-1.png)
![semaglutide 2.4 mg weekly PDF] 2·4 once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Semaglutide versus placebo in individuals](https://scx2.b-cdn.net/gfx/news/hires/2025/ozempic-4.jpg)
![semaglutide 2.4 mg weekly PDF] 2·4 once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Semaglutide versus placebo in individuals](https://www.mountainside-medical.com/cdn/shop/files/Wegovy-_semaglutide_-Weight-Loss-Pen-Injector-2.4-mg.jpg?v=1684507038)
![semaglutide 2.4 mg weekly PDF] 2·4 once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Semaglutide versus placebo in individuals](https://www.clinicalnutritioncenter.com/wp-content/uploads/2021/02/semaglutide-weight-loss.jpg)
semaglutide 2.4 mg weekly
Shipping Estimate
semaglutide 2.4 mg weekly PDF] 2·4 once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Semaglutide versus placebo in individuals
USD24.73
USD61.73
Pay in 4 interest-free payments of $6.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
![semaglutide 2.4 mg weekly PDF] 24 once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Semaglutide versus placebo in individuals](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-026-04416-4/MediaObjects/41591_2026_4416_Fig2_HTML.png)
![semaglutide 2.4 mg weekly PDF] 24 once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Semaglutide versus placebo in individuals](https://sciencehub.novonordisk.com/content/dam/sciencehub/global/en/congresses-and-scientific-publications/scientific-publications/articles/8/38330988/images/step-7-pls-infographic.jpg)
![semaglutide 2.4 mg weekly PDF] 24 once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Semaglutide versus placebo in individuals](https://static.wixstatic.com/media/2687dd_c06055c300e7413fab7a7a2838734ddd~mv2.webp/v1/fill/w_568,h_320,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/2687dd_c06055c300e7413fab7a7a2838734ddd~mv2.webp)
![semaglutide 2.4 mg weekly PDF] 24 once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Semaglutide versus placebo in individuals](https://ars.els-cdn.com/content/image/1-s2.0-S0140673621002130-gr2.jpg)
![semaglutide 2.4 mg weekly PDF] 24 once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Semaglutide versus placebo in individuals](https://www.thelancet.com/cms/asset/e52a65a7-8607-4967-8701-3c310d11632e/gr1.jpg)
